The Journal of Clinical Psychopharmacology Podcast
By The Journal of Clinical Psychopharmacology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 13
Reviews: 0
Episodes: 41
Description
A podcast detailing current topics in the Journal of Clinical Psychopharmacology.
| Episode | Date |
|---|---|
|
A Case of Tachyphylaxis After Long-Term Intravenous Racemic Ketamine for Treatment-Resistant Depression
|
Apr 29, 2024 |
|
Glucagon-Like Peptide 1 Receptor Agonists in Psychiatry
|
Apr 29, 2024 |
|
Clinical Presentations of Bupropion Prescription Drug Misuse: A Systematic Review
|
Apr 29, 2024 |
|
The Role of Case Series and Case Reports in Evidence-Based Medicine
|
Feb 28, 2024 |
|
Current Status and Treatment of Rapid Cycling Bipolar Disorder
|
Feb 28, 2024 |
|
GLP-1 Weight Loss Drugs in Patients With Bipolar Disorder or Eating Disorders
|
Feb 28, 2024 |
|
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?
|
Dec 15, 2023 |
|
Direct-to-Consumer Advertising Survey of Psychiatrists in Massachusetts and Michigan
|
Dec 15, 2023 |
|
The Need for Examining the Role of Psychostimulants in Treatment of Methamphetamine Use/Dependence
|
Nov 01, 2023 |
|
Assessing Adherence to Clozapine: Practical Considerations
|
Sep 06, 2023 |
|
Artificial Intelligence and the Journal of Clinical Psychopharmacology
|
Sep 06, 2023 |
|
Adherence to Psychotropic Medication Before and During COVID-19: A Population-Wide Retrospective Observational Study
|
Jun 30, 2023 |
|
A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials
|
Jun 30, 2023 |
|
Valproic Acid–Associated Hyperammonemia: A Systematic Review
|
Apr 25, 2023 |
|
Anosognosia and Psychosis: More Research is Needed on How Best to Treat People Unaware of Their Disorder
|
Apr 25, 2023 |
|
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine
|
Feb 24, 2023 |
|
Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients With Treatment-Resistant Schizophrenia
|
Feb 24, 2023 |
|
Real-World Clinical Practice Among Patients With Bipolar Disorder and Chronic Kidney Disease on Long-term Lithium Therapy
|
Jan 03, 2023 |
|
Endoxifen Approval for Bipolar Disorder in India: A Premature or a Pragmatic Decision?
|
Jan 03, 2023 |
|
Psychedelics in the Treatment of Depression: A Critical Appraisal of Evidence
|
Nov 04, 2022 |
|
The Modernization of Clozapine: A Recapitulation of the Past in the United States and the View Forward
|
Nov 04, 2022 |
|
Effects of Selective Serotonin Reuptake Inhibitor Use on MDMA–Assisted Therapy for Posttraumatic Stress Disorder
|
Aug 30, 2022 |
|
Exposure to SARS-CoV-2, Acute Kidney Injury, and Lithium Toxicity
|
Aug 30, 2022 |
|
Panic Disorder Seeks More Specific Drugs for Treatment : Might the Amygdala Be the Best Target?
|
Aug 30, 2022 |
|
Unfair Criticisms of Psychopharmacology
|
Jul 01, 2022 |
|
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series
|
Jul 01, 2022 |
|
Should Antipsychotic Medications Be Prescribed to Patients with Nonpsychotic Depression?
|
Apr 29, 2022 |
|
Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents
|
Apr 29, 2022 |
|
Calcium Channel Antagonists for Mood Disorders
|
Mar 01, 2022 |
|
Structured Interventions to Optimize Polypharmacy in Psychiatric Treatment and Nursing Homes: A Systematic Review
|
Mar 01, 2022 |
|
Raising the Quality of Psychopharmacology Care
|
Dec 22, 2021 |
|
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs
|
Dec 14, 2021 |
|
Are the same medications that are used in the acute treatment of depression the most suitable for preventing relapse?
|
Nov 04, 2021 |
|
Lifetime cannabis use disorder is not associated with lifetime impulsive behavior and severe violence in patients with schizophrenia spectrum disorders from a high-security hospital
|
Nov 04, 2021 |
|
Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior
|
Aug 20, 2021 |
|
The Placenta and Psychiatry?
|
Aug 20, 2021 |
|
Time to reconsider monoamine oxidase inhibitors (MAOIs) for Obsessive Compulsive Disorder? A case series using phenelzine
|
Jul 08, 2021 |
|
Domestic Mass Shooters: The Association With Unmedicated and Untreated Psychiatric Illness
|
Jun 23, 2021 |
|
Why Is There No Food and Drug Administration–Approved Medication for Major Depression With Psychotic Features?
|
Jun 23, 2021 |
|
Esketamine: A Drug to Treat Resistant Depression That Brings More Questions Than Answers
|
May 10, 2021 |
|
The Pitfalls of Psychotropic Polypharmacy
|
Apr 22, 2021 |